Printer Friendly
The Free Library
14,529,872 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Pharmaceutical industry topic

Management subtopic

 

Articles

1-100 out of 100 article(s)
Title Author Type Date Words
Wall Street doesn't hold breath on inhaled insulin; MannKind stock tumbles after deal with marketing partner collapses. Proctor, Charles Company overview Oct 12, 2009 717
UAS Laboratories: prizing the power of probiotics. Company overview Sep 1, 2009 826
Production and Manufacturing. Directory Sep 1, 2009 1924
Pharmachem Laboratories: a decade of expansion. Company overview Sep 1, 2009 723
Opportunities off the beaten track in the knowledge outsourcing field: a knowledge process outsourcing sector doing well even in these challenging times is in the healthcare and pharmaceutical knowledge space. Some argue that the scale is too small to consider growth but not being overloaded has helped such companies to do well. Dutt, Ashish Aug 1, 2009 1146
Amylin board headed for showdown: investors battling for control of the business. Chambers, Heather May 25, 2009 762
Vacuum pumps for pharmaceutical processes: Dr Don Collins, Market Development Manager, Chemical Sector, Edwards, discusses vacuum pumping technologies and how pharmaceutical manufacturing managers can optimize their vacuum processes. Collins, Don May 1, 2009 1797
New problems, new CRM solutions. Giardina, Annette May 1, 2009 1065
ActiTech. Company overview Mar 1, 2009 281
Alkemists Labs. Company overview Mar 1, 2009 434
Blue California. Company overview Mar 1, 2009 440
Gencor Nutrients, Inc. Company overview Mar 1, 2009 306
Indena. Company overview Mar 1, 2009 424
ProTab Laboratories. Company overview Mar 1, 2009 281
Robinson Pharma Inc. Company overview Mar 1, 2009 448
The way of the regulator: applying pharmaceutical principles now could pave the way to a risk-free future. Robinson, Kevin Editorial Mar 1, 2009 814
IP Snapshot - January 2009. Feb 4, 2009 921
Promotion Of Drugs and Devices At International Conferences Held In Canada. Feb 4, 2009 2059
Winning The Battle Against Trademark Counterfeiting Through Third Party Enforcement. Feb 4, 2009 1516
Modern CROS: an attractive solution for the pharmaceutical industry: Jonathan McNally, vertical marketing manager, Thermo fisher Scientific, discusses why contract research organizations (CROs) are an attractive solution in these difficult times. McNally, Jonathan Jan 1, 2009 1492
New insourcing model breaks drug development mould: ever wondered where to source senior management expertise to achieve success in drug development on a completely 'as and when' basis from a single source? TranScrip Partners offers such a service, as Senior Partner, Paul Branthwaite, discusses in a Q&A with Pharma. Branthwaite, Paul Interview Jan 1, 2009 940
Secrets out? Outside of the world of tv and movies, espionage doesn't feature much in our day-to-day lives. But when it comes to business, we might wonder whether event organizers are overlooking a crucial detail when planning meetings and conferences. Jan 1, 2009 811
Reconnect with Mother Earth. Company overview Jan 1, 2009 454
Ed Kim, MD, MBA: making the move to pharma. Weimar, Carrie Jan 1, 2009 1255
The world finds relief in Littleton firm's products: Tender Corp.'s presence continues to grow steadily around the globe. Stone, Tracie Company overview Nov 21, 2008 904
Predicting your health: Bloomington startup to go national. Mayer, Kathy Nov 1, 2008 367
What Does The Third Amendment To China's Patent Law Mean To Pharmaceutical Companies? Aug 27, 2008 1364
Hatching innovation: duo seeks to tap ex-Amgen workers for Agoura Hills startup incubator. Proctor, Charles Aug 25, 2008 1216
Huya targeting China to accelerate drug production: strategy allows for less costly trials, fewer risks. Chambers, Heather Jul 21, 2008 648
New drugmaker ethical code may be relevant for device companies. Langdon, Mark Jul 1, 2008 1318
Adopting the CEO model--why physician executives should not be required to practice medicine. Lazarus, Arthur Jul 1, 2008 1584
Drug companies drain scientific brains from FDA, leaving less confident staff. Jun 17, 2008 495
Sins of omission: drug companies twist the evidence about antidepressants. Gaby, Alan R. May 1, 2008 664
Collaborate for competitive success! May 1, 2008 1150
Inhaled-insulin maker feels pain of rival product's flop. Crowe, Deborah Company overview Apr 14, 2008 484
Pharmacy board to weigh delays on drug tracking. Chambers, Heather Mar 24, 2008 499
Amerilab Technologies, Inc. Company overview Mar 1, 2008 401
Cepham Inc. Company overview Mar 1, 2008 614
Cognis[R] Nutrition & Health. Company overview Mar 1, 2008 407
Gencor Pacific Inc. Company overview Mar 1, 2008 320
Improve USA, Inc. Company overview Mar 1, 2008 227
Indena. Company overview Mar 1, 2008 427
Lonza. Company overview Mar 1, 2008 444
Robinson Pharma Inc. Company overview Mar 1, 2008 433
Ruger Chemical Co., Inc. Company overview Mar 1, 2008 537
Schaefer Technologies, Inc. Company overview Mar 1, 2008 180
Science inspired by nature. Robinson, Kevin Company overview Mar 1, 2008 3009
Engaging the search: businesses are looking for solutions online. Are they finding you? Kelly Howard, Executive Vice President, ABI, reviews the options to increase a company's profile online. Howard, Kelly Mar 1, 2008 1661
Puerto Rico's Gov. to visit drug firms Acevedo-Vila expected to ink pact with Biocom. Chambers, Heather Feb 18, 2008 813
Legislation Proposed To Govern Use Of Deferred Prosecution Agreements, Selection Of Monitors, In Corporate Fraud Investigations. Feb 7, 2008 826
RushNet expands. Brief article Feb 1, 2008 108
We can work with pharma. McNeil, David Editorial Feb 1, 2008 649
Lost in the holiday shuffle: mergers, spin-offs, settlements. Sanders, Bob Jan 18, 2008 1299
Pfizer expanding incubator concept to Bay Area, Boston: pharma giant to invest millions over five years. Chambers, Heather Jan 14, 2008 839
Hello from me. Lampard, Graham Brief article Jan 1, 2008 282
Bank charges: a hard pill to swallow for pharma: bank charges cost the pharma industry hundreds of thousands of pounds a year and UK pharmaceutical companies are spending half a million pounds to recover missing funds, so Peter Burridge Managing Director of foreign exchange experts Travelex, says. Burridge, Peter Guest editorial Jan 1, 2008 316
Exeter. Brief article Dec 7, 2007 79
Participants uninformed in some halted trials. Nov 5, 2007 670
Using multi-hub structures for international R&D: organisational inertia and the challenges of implementation. Criscuolo, Paola; Narula, Rajneesh Nov 1, 2007 7525
Skilled Nursing Pharmacy has signed a five-year lease for 5,062 square feet of industrial space located at 9920 Scripps Lake Drive, Suite 108, in Scripps Ranch. Schweizer, Andrew Brief article Oct 22, 2007 59
Mindstorm: simulating psychosis; A new virtual reality experience depicts hallucinations in 3-D. Tabar, Pamela Oct 1, 2007 1108
Strategic audit: Tony Grundy explains why it's vital to give your strategy a health check. Grundy, Tony Sep 1, 2007 1382
The networked industry and its pitfalls: in the following paper, Adriana Salvatore and Paolo Prisco from BearingPoint, discuss the opportunities and associated risks using a network of external professionals. The potential implications of such risks and the relevant measures that companies should put in place are detailed. Salvatore, Adriana; Prisco, Paolo Sep 1, 2007 1349
Industry and psychiatry: physician, heal thyself. Fullerton, Catherine A. Viewpoint essay Jul 1, 2007 900
Clinton to lower cost of AIDS drugs. Brief article Jun 1, 2007 124
Cardinal becomes Catalent. Brief article Jun 1, 2007 256
More with less. Weeks, Katie Brief article Apr 16, 2007 166
Human infectious diseases remain focus of vicars vaccine research: biotech boasts plentiful pipeline, two drugs in late phase trials. Weeks, Katie Apr 2, 2007 897
Bioenergy Life Science, Inc. Company overview Mar 1, 2007 373
Indena. Company overview Mar 1, 2007 422
Lomapharm. Brief article Mar 1, 2007 263
Novum, LLC. Company overview Mar 1, 2007 266
Robinson Pharma. Company overview Mar 1, 2007 316
Stella Labs. Company overview Mar 1, 2007 424
Pharma expanding post-market surveillance, says PwC report. Feb 26, 2007 315
How drug companies use bully tactics to get your business. Feb 1, 2007 1086
Indena: a natural at botanical production. Company overview Jan 1, 2007 658
The Russian Federation: prescription for growth: the Russian pharmaceuticals market is growing very fast, and the clinical trials sector is booming. But any company that wants to do business there faces considerable challenges, as Simon Friend PricewaterhauseCoopers global pharmaceutical leader, explains. Friend, Simon Jan 1, 2007 3804
Who are those guys? Using anonymized patient-level intelligence to size and characterize an undiagnosed population: anonymized patient-level intelligence can be used to provide more accurate insights into the prediabetic population. Carroll, Jim; Tirrell, Taryn Dec 1, 2006 950
Gencor Pacific Inc.: a traditional approach to lifestyle management. Company overview Dec 1, 2006 755
Inovio Biomedical Corp. bouncing back from shaky past, facing critical year: company raises $15.5m in sale of stock, gains $1.1m grant from U.S. Department of Defense. Weeks, Katie Nov 6, 2006 719
Pharmaceutical representatives can deliver the brand promise: the sales representative plays a critical role in the marketing and branding processes. To do this, pharmaceutical reps in the field must constantly be in tune with the purpose of the companies they represent. Barlow, Janelle; Wardlaw, Jim Nov 1, 2006 2023
Developing end-of-lifecycle strategies. Naigamwalla, Darius Nov 1, 2006 575
Divide and conquer: novel patient-segmentation approach leads to new opportunities: anonymized patient-level data can be used to segment patients according to clinical factors, therapy usage, and demographics, allowing pharmaceutical companies to reach the right physicians and patients with the right messages. Carroll, Jim; Tirrell, Taryn Oct 1, 2006 1149
Who really "Moves the Needle?" How to focus resources on the most important payer accounts. Lanzone, Tony Oct 1, 2006 1745
Are You Making The Most Of The Explosion In Proprietary Device Technology? Brief article Sep 13, 2006 240
Global Pharmatech, Inc. Brief article Sep 1, 2006 87
The Benefits of Patents for Nutraceuticals. Aug 30, 2006 1615
Cervical cancer R&D continues locally despite new vaccine: life sciences firms seek their share of $650 million market. Weeks, Katie Aug 7, 2006 990
NIH scientist netted $285,000 by improperly sharing human tissue samples with Pfizer-House report. Jun 30, 2006 572
SNT-MC17/idebenone--a promising drug candidate for Friedreich's Ataxia (FRDA). Meier, Thomas Jun 22, 2006 1415
Companies to watch: the fab five. Wright, Rebecca Editorial Jun 1, 2006 4632
Anabolic Laboratories, Inc. Company overview Mar 1, 2006 327
Indena. Company overview Mar 1, 2006 462
Major firms agree to disclose political gifts. Heffes, Ellen M. Brief article Mar 1, 2006 268
S.D. biotech, Kansas firm part ways. Weeks, Katie Feb 13, 2006 338
Biotech success could lead to CytRx payoff, but there's risk. Crowe, Deborah Company Profile Feb 13, 2006 818
Campaign promotes discount drug program. Weeks, Katie Jan 30, 2006 613
UCSD considers altering clinical trial procedures: change could affect how fast some drugs get on the market. Weeks, Katie Nov 14, 2005 1049
Freshly washed: drug dealers, corporate swindlers cash in profits as money laundering continues to damage national image. Messenger, Rawdon May 1, 2004 1825

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles